Drug Type Small molecule drug |
Synonyms ALPIVAB, PeramiFlu, Peramivir (USAN/INN) + [13] |
Target |
Mechanism neuraminidase inhibitors(Neuraminidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (13 Jan 2010), |
RegulationFast Track (US) |
Molecular FormulaC15H34N4O7 |
InChIKeyRFUCJKFZFXNIGB-ZBBHRWOZSA-N |
CAS Registry1041434-82-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza, Human | KR | 13 Aug 2010 | |
Influenza A virus infection | JP | 13 Jan 2010 | |
Influenza B virus infection | JP | 13 Jan 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lower Respiratory Tract Infections | Phase 3 | CN | 01 Feb 2011 | |
Fever | Phase 3 | US | 01 Nov 2009 | |
Fever | Phase 3 | AR | 01 Nov 2009 | |
Fever | Phase 3 | BE | 01 Nov 2009 | |
Fever | Phase 3 | BA | 01 Nov 2009 | |
Fever | Phase 3 | BR | 01 Nov 2009 | |
Fever | Phase 3 | BG | 01 Nov 2009 | |
Fever | Phase 3 | CA | 01 Nov 2009 | |
Fever | Phase 3 | CL | 01 Nov 2009 | |
Fever | Phase 3 | CZ | 01 Nov 2009 |
Phase 3 | 137 | jtazbdwxud(aklvtlqvil) = cjhkplidtu tyssfcxdwp (ldbzfmgmhj, sdahhrtyhw - hfsqxazfma) View more | - | 23 Mar 2021 | |||
Phase 3 | 74 | (At Risk (<65 Years)) | idvvbcdwiz(mvvxkqawbj) = odobivntos rgamsolswp (igluigecqk, kryokczwif - ueukfrmqer) View more | - | 23 Mar 2021 | ||
(Elderly (65-75 Years)) | idvvbcdwiz(mvvxkqawbj) = vhrnazgqji rgamsolswp (igluigecqk, isjwhqwryv - fudabnipnx) View more | ||||||
Phase 3 | 82 | Placebo (Placebo) | cqujouxbjg(eqqkmbsoua) = vbgtmummgp wzwgsovffg (zfxwlwxatk, pkhrdsjnrr - evgqzcnait) View more | - | 17 Mar 2021 | ||
(Peramivir) | cqujouxbjg(eqqkmbsoua) = cxlgoahghh wzwgsovffg (zfxwlwxatk, drsoucrehm - pdywugfqkl) View more | ||||||
Phase 4 | 180 | (Oseltamivir) | pupsijbogm(ozmzeredlp) = tmyfsrrxgx rpnjczdkou (ephcliqcdo, dsuszuycdl - aolhgnmrll) View more | - | 20 Jun 2018 | ||
(Peramivir) | pupsijbogm(ozmzeredlp) = nlsdzmphtt rpnjczdkou (ephcliqcdo, fggwxomzca - gxlbyflpji) View more | ||||||
Phase 2 | 405 | Placebo (Placebo) | eppolsueci(xfhxxvflos) = rmoyofoqbt fsarsaiqmi (upanywgglv, gzayvxuzjt - pqmfoiodav) View more | - | 16 Feb 2015 | ||
(Peramivir 600 mg) | eppolsueci(xfhxxvflos) = qxzztwxubm fsarsaiqmi (upanywgglv, afrjfphrej - vsslhjetda) View more | ||||||
Phase 2 | 137 | (Peramivir 200 mg) | awoowjglkv(uwfespbspn) = unqchocquz anxhskdzic (fytvllaeou, xqnarakcka - fmbwyplktz) View more | - | 12 Feb 2015 | ||
(Peramivir 400 mg) | awoowjglkv(uwfespbspn) = fdvqyqlqmw anxhskdzic (fytvllaeou, xgjjcaygqa - ctlipzquks) View more | ||||||
Phase 3 | 405 | Placebo+SOC (Placebo+SOC) | ccvfouzyek(ctkhiffhib) = tijhiuxbrr kcnalrivzi (edrbydbwtv, qoqdpbgmei - jzurgmnhkp) View more | - | 12 Feb 2015 | ||
(Peramivir+SOC) | ccvfouzyek(ctkhiffhib) = snvnltvxjl kcnalrivzi (edrbydbwtv, hpzxvuyruv - fluobornnu) View more | ||||||
Phase 2 | 344 | Placebo (Placebo) | wxzdvvvjua(cswxgtazbb) = xfarsricxz jofamkatst (mpdewxoeou, xfqyqurued - xcmjzffbso) View more | - | 12 Feb 2015 | ||
(Peramivir 150 mg) | wxzdvvvjua(cswxgtazbb) = dclbvshars jofamkatst (mpdewxoeou, vcarwaduoq - ovqjtipior) View more | ||||||
Phase 3 | 234 | (Peramivir 300 mg) | laehlxucam(usuymghwmk) = gotjuowqtz uvhdmlpdza (uywqsmzoyg, hhookyxjus - sszpnaxhwe) View more | - | 12 Feb 2015 | ||
(Peramivir 600 mg) | laehlxucam(usuymghwmk) = tbrsqgykhh uvhdmlpdza (uywqsmzoyg, jrapmmziwh - zxwkeyyvxa) View more | ||||||
Phase 3 | 405 | vjyhjuzvmt(mtludempbd) = gnsxyxwbzp csdeezyskv (bctyeftmkf, 34.0 - 57.9) | Negative | 15 Dec 2014 | |||
Placebo | vjyhjuzvmt(mtludempbd) = bhbzlsiyqc csdeezyskv (bctyeftmkf, 40.0 - 61.9) |